 | • レポートコード：QYR9ST04689 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、成人悪性神経膠腫治療の世界市場について調査・分析し、成人悪性神経膠腫治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（化学療法、標的薬物療法、放射線療法）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の成人悪性神経膠腫治療市場動向 ・主要企業別マーケットシェア ・成人悪性神経膠腫治療の種類別市場規模2014-2019 （化学療法、標的薬物療法、放射線療法） ・成人悪性神経膠腫治療の用途別市場規模2014-2019 （病院、診療所、その他） ・成人悪性神経膠腫治療の北米市場：主要企業・種類別/用途別市場規模 ・成人悪性神経膠腫治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・成人悪性神経膠腫治療の中国市場：主要企業・種類別/用途別市場規模 ・成人悪性神経膠腫治療の日本国内市場：主要企業・種類別/用途別市場規模 ・成人悪性神経膠腫治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・成人悪性神経膠腫治療のインド市場：主要企業・種類別/用途別市場規模 ・成人悪性神経膠腫治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Merck、Roche、Arbor Pharmaceuticals、Pfizer、AbbVie、Amgen、Bristol-Myers Squibb、Sun Pharmaceuticals、Teva Pharmaceutical、Emcure Pharmaceuticals） ・成人悪性神経膠腫治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Glioblastoma multiforme (GBM) is among the most difficult of tumors to treat, and despite all efforts, median overall survival remains at approximately 12 months. Malignant gliomas are included in the category of rare diseases, and the orphan drug status is granted for the drug candidates in the pipeline.In terms of type, the global adult malignant glioma therapeutics market has been classified into glioblastoma multiforme, anaplastic astrocytoma, anaplastic oligodendroglioma, anaplastic oligoastrocytoma, and others. Glioblastoma multiforme, which accounts for 12% to 15% of all intracranial tumors and 50% to 60% of all astrocytic tumors, is likely to be the most attractive segment during the forecast period, followed by anaplastic astrocytoma.
North America dominated the global market in 2017, accounting for over 35% share in terms of revenue. Europe was another major market for adult malignant glioma therapeutics in 2017. Technological advancement is a major driver of the market in North America and Europe.
In 2018, the global Adult Malignant Glioma Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Adult Malignant Glioma Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Adult Malignant Glioma Therapeutics development in United States, Europe and China.
The key players covered in this study
Merck
Roche
Arbor Pharmaceuticals
Pfizer
AbbVie
Amgen
Bristol-Myers Squibb
Sun Pharmaceuticals
Teva Pharmaceutical
Emcure Pharmaceuticals
Market segment by Type, the product can be split into
Chemotherapy
Targeted Drug Therapy
Radiation Therapy
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Adult Malignant Glioma Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Adult Malignant Glioma Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Adult Malignant Glioma Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Adult Malignant Glioma Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Targeted Drug Therapy
1.4.4 Radiation Therapy
1.5 Market by Application
1.5.1 Global Adult Malignant Glioma Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Adult Malignant Glioma Therapeutics Market Size
2.2 Adult Malignant Glioma Therapeutics Growth Trends by Regions
2.2.1 Adult Malignant Glioma Therapeutics Market Size by Regions (2014-2025)
2.2.2 Adult Malignant Glioma Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Adult Malignant Glioma Therapeutics Market Size by Manufacturers
3.1.1 Global Adult Malignant Glioma Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Adult Malignant Glioma Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Adult Malignant Glioma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Adult Malignant Glioma Therapeutics Key Players Head office and Area Served
3.3 Key Players Adult Malignant Glioma Therapeutics Product/Solution/Service
3.4 Date of Enter into Adult Malignant Glioma Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Adult Malignant Glioma Therapeutics Market Size by Type (2014-2019)
4.2 Global Adult Malignant Glioma Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Adult Malignant Glioma Therapeutics Market Size (2014-2019)
5.2 Adult Malignant Glioma Therapeutics Key Players in United States
5.3 United States Adult Malignant Glioma Therapeutics Market Size by Type
5.4 United States Adult Malignant Glioma Therapeutics Market Size by Application
6 Europe
6.1 Europe Adult Malignant Glioma Therapeutics Market Size (2014-2019)
6.2 Adult Malignant Glioma Therapeutics Key Players in Europe
6.3 Europe Adult Malignant Glioma Therapeutics Market Size by Type
6.4 Europe Adult Malignant Glioma Therapeutics Market Size by Application
7 China
7.1 China Adult Malignant Glioma Therapeutics Market Size (2014-2019)
7.2 Adult Malignant Glioma Therapeutics Key Players in China
7.3 China Adult Malignant Glioma Therapeutics Market Size by Type
7.4 China Adult Malignant Glioma Therapeutics Market Size by Application
8 Japan
8.1 Japan Adult Malignant Glioma Therapeutics Market Size (2014-2019)
8.2 Adult Malignant Glioma Therapeutics Key Players in Japan
8.3 Japan Adult Malignant Glioma Therapeutics Market Size by Type
8.4 Japan Adult Malignant Glioma Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Adult Malignant Glioma Therapeutics Market Size (2014-2019)
9.2 Adult Malignant Glioma Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Adult Malignant Glioma Therapeutics Market Size by Type
9.4 Southeast Asia Adult Malignant Glioma Therapeutics Market Size by Application
10 India
10.1 India Adult Malignant Glioma Therapeutics Market Size (2014-2019)
10.2 Adult Malignant Glioma Therapeutics Key Players in India
10.3 India Adult Malignant Glioma Therapeutics Market Size by Type
10.4 India Adult Malignant Glioma Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Adult Malignant Glioma Therapeutics Market Size (2014-2019)
11.2 Adult Malignant Glioma Therapeutics Key Players in Central & South America
11.3 Central & South America Adult Malignant Glioma Therapeutics Market Size by Type
11.4 Central & South America Adult Malignant Glioma Therapeutics Market Size by Application
12 International Players Profiles
12.1 Merck
12.1.1 Merck Company Details
12.1.2 Company Description and Business Overview
12.1.3 Adult Malignant Glioma Therapeutics Introduction
12.1.4 Merck Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019)
12.1.5 Merck Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Adult Malignant Glioma Therapeutics Introduction
12.2.4 Roche Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019)
12.2.5 Roche Recent Development
12.3 Arbor Pharmaceuticals
12.3.1 Arbor Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Adult Malignant Glioma Therapeutics Introduction
12.3.4 Arbor Pharmaceuticals Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019)
12.3.5 Arbor Pharmaceuticals Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Adult Malignant Glioma Therapeutics Introduction
12.4.4 Pfizer Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 AbbVie
12.5.1 AbbVie Company Details
12.5.2 Company Description and Business Overview
12.5.3 Adult Malignant Glioma Therapeutics Introduction
12.5.4 AbbVie Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019)
12.5.5 AbbVie Recent Development
12.6 Amgen
12.6.1 Amgen Company Details
12.6.2 Company Description and Business Overview
12.6.3 Adult Malignant Glioma Therapeutics Introduction
12.6.4 Amgen Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019)
12.6.5 Amgen Recent Development
12.7 Bristol-Myers Squibb
12.7.1 Bristol-Myers Squibb Company Details
12.7.2 Company Description and Business Overview
12.7.3 Adult Malignant Glioma Therapeutics Introduction
12.7.4 Bristol-Myers Squibb Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019)
12.7.5 Bristol-Myers Squibb Recent Development
12.8 Sun Pharmaceuticals
12.8.1 Sun Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Adult Malignant Glioma Therapeutics Introduction
12.8.4 Sun Pharmaceuticals Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019)
12.8.5 Sun Pharmaceuticals Recent Development
12.9 Teva Pharmaceutical
12.9.1 Teva Pharmaceutical Company Details
12.9.2 Company Description and Business Overview
12.9.3 Adult Malignant Glioma Therapeutics Introduction
12.9.4 Teva Pharmaceutical Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019)
12.9.5 Teva Pharmaceutical Recent Development
12.10 Emcure Pharmaceuticals
12.10.1 Emcure Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Adult Malignant Glioma Therapeutics Introduction
12.10.4 Emcure Pharmaceuticals Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019)
12.10.5 Emcure Pharmaceuticals Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Adult Malignant Glioma Therapeutics Key Market Segments
Table Key Players Adult Malignant Glioma Therapeutics Covered
Table Global Adult Malignant Glioma Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Adult Malignant Glioma Therapeutics Market Size Market Share by Type 2014-2025
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Targeted Drug Therapy Figures
Table Key Players of Targeted Drug Therapy
Figure Radiation Therapy Figures
Table Key Players of Radiation Therapy
Table Global Adult Malignant Glioma Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Adult Malignant Glioma Therapeutics Report Years Considered
Table Global Adult Malignant Glioma Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Adult Malignant Glioma Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Adult Malignant Glioma Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Adult Malignant Glioma Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Adult Malignant Glioma Therapeutics Market Share by Regions 2014-2019
Figure Global Adult Malignant Glioma Therapeutics Market Share by Regions 2014-2019
Figure Global Adult Malignant Glioma Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Adult Malignant Glioma Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Adult Malignant Glioma Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Adult Malignant Glioma Therapeutics Market Share by Manufacturers in 2018
Table Global Adult Malignant Glioma Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Adult Malignant Glioma Therapeutics Product/Solution/Service
Table Date of Enter into Adult Malignant Glioma Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Adult Malignant Glioma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Adult Malignant Glioma Therapeutics Market Size Share by Type (2014-2019)
Figure Global Adult Malignant Glioma Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Adult Malignant Glioma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Adult Malignant Glioma Therapeutics Market Size Share by Application (2014-2019)
Figure Global Adult Malignant Glioma Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Adult Malignant Glioma Therapeutics Revenue Market Share by Application in 2018
Figure United States Adult Malignant Glioma Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Adult Malignant Glioma Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Adult Malignant Glioma Therapeutics Market Share (2018-2019)
Table United States Adult Malignant Glioma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Adult Malignant Glioma Therapeutics Market Share by Type (2014-2019)
Table United States Adult Malignant Glioma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Adult Malignant Glioma Therapeutics Market Share by Application (2014-2019)
Figure Europe Adult Malignant Glioma Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Adult Malignant Glioma Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Adult Malignant Glioma Therapeutics Market Share (2018-2019)
Table Europe Adult Malignant Glioma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Adult Malignant Glioma Therapeutics Market Share by Type (2014-2019)
Table Europe Adult Malignant Glioma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Adult Malignant Glioma Therapeutics Market Share by Application (2014-2019)
Figure China Adult Malignant Glioma Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Adult Malignant Glioma Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Adult Malignant Glioma Therapeutics Market Share (2018-2019)
Table China Adult Malignant Glioma Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Adult Malignant Glioma Therapeutics Market Share by Type (2014-2019)
Table China Adult Malignant Glioma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Adult Malignant Glioma Therapeutics Market Share by Application (2014-2019)
Figure Japan Adult Malignant Glioma Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Adult Malignant Glioma Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Adult Malignant Glioma Therapeutics Market Share (2018-2019)
Table Japan Adult Malignant Glioma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Adult Malignant Glioma Therapeutics Market Share by Type (2014-2019)
Table Japan Adult Malignant Glioma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Adult Malignant Glioma Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Adult Malignant Glioma Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Adult Malignant Glioma Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Adult Malignant Glioma Therapeutics Market Share (2018-2019)
Table Southeast Asia Adult Malignant Glioma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Adult Malignant Glioma Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Adult Malignant Glioma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Adult Malignant Glioma Therapeutics Market Share by Application (2014-2019)
Figure India Adult Malignant Glioma Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Adult Malignant Glioma Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Adult Malignant Glioma Therapeutics Market Share (2018-2019)
Table India Adult Malignant Glioma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Adult Malignant Glioma Therapeutics Market Share by Type (2014-2019)
Table India Adult Malignant Glioma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Adult Malignant Glioma Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Adult Malignant Glioma Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Adult Malignant Glioma Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Adult Malignant Glioma Therapeutics Market Share (2018-2019)
Table Central & South America Adult Malignant Glioma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Adult Malignant Glioma Therapeutics Market Share by Type (2014-2019)
Table Central & South America Adult Malignant Glioma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Adult Malignant Glioma Therapeutics Market Share by Application (2014-2019)
Table Merck Company Details
Table Merck Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019) (Million US$)
Figure Merck Revenue Growth Rate in Adult Malignant Glioma Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Roche Company Details
Table Roche Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Adult Malignant Glioma Therapeutics Business (2014-2019)
Table Roche Recent Development
Table Arbor Pharmaceuticals Company Details
Table Arbor Pharmaceuticals Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019)(Million US$)
Figure Arbor Pharmaceuticals Revenue Growth Rate in Adult Malignant Glioma Therapeutics Business (2014-2019)
Table Arbor Pharmaceuticals Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Adult Malignant Glioma Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Adult Malignant Glioma Therapeutics Business (2014-2019)
Table AbbVie Recent Development
Table Amgen Company Details
Table Amgen Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Adult Malignant Glioma Therapeutics Business (2014-2019)
Table Amgen Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Adult Malignant Glioma Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Sun Pharmaceuticals Company Details
Table Sun Pharmaceuticals Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019)(Million US$)
Figure Sun Pharmaceuticals Revenue Growth Rate in Adult Malignant Glioma Therapeutics Business (2014-2019)
Table Sun Pharmaceuticals Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Adult Malignant Glioma Therapeutics Business (2014-2019)
Table Teva Pharmaceutical Recent Development
Table Emcure Pharmaceuticals Company Details
Table Emcure Pharmaceuticals Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019)(Million US$)
Figure Emcure Pharmaceuticals Revenue Growth Rate in Adult Malignant Glioma Therapeutics Business (2014-2019)
Table Emcure Pharmaceuticals Recent Development
Table Global Adult Malignant Glioma Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Adult Malignant Glioma Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Adult Malignant Glioma Therapeutics Market Size Share by Regions in 2025
Figure United States Adult Malignant Glioma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Adult Malignant Glioma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Adult Malignant Glioma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Adult Malignant Glioma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Adult Malignant Glioma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Adult Malignant Glioma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Adult Malignant Glioma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Adult Malignant Glioma Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Adult Malignant Glioma Therapeutics Market Size by Product (2019-2025)
Figure Global Adult Malignant Glioma Therapeutics Market Size by Product in 2025
Table Global Adult Malignant Glioma Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Adult Malignant Glioma Therapeutics Market Size by Application (2019-2025)
Figure Global Adult Malignant Glioma Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
悪性神経膠腫治療の世界市場：市場規模・現状・予測 Malignant glioma's are one of the common sub-type of primary brain tumors which are highly invasive, aggressive and neurologically destructive tumors among the deadliest human cancers.In the Malignant Glioma Market the largest market share is gained by the U.S. where there are large incidence and pr…- 世界の橋膠腫薬市場：専門的調査 The global Pontine Glioma Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Pontine Glioma Drug volume and value at global level, regional level and company level. From a global perspective, this…
- 急性骨髄性白血病（AML）治療薬の世界市場：市場規模・現状・予測 In 2018, the global Acute Myeloid Leukemia (AML) Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Acute Myeloid Leukemia (AML) Therapeutics status, future forecast, growth…
- 放射線治療装置の世界市場：市場規模・現状・予測 In 2018, the global Radiation Therapy Equipment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Radiation Therapy Equipment status, future forecast, growth opportunity, key market and…
- 放射線治療装置の世界市場：市場規模・現状・予測 In 2018, the global Radiation Therapy Equipment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Radiation Therapy Equipment status, future forecast, growth opportunity, key market and…